The goal of this study to learn if the combination of everolimus and sorafenib can help to control malignant glioma.
Clinical Trial Information
Trial Contact: Ferry, Robert, P.
Trial Phone: 321-841-1077
Age Group: Adult
Phase: Drug: Phase I
Principal Investigator: Nicholas G. Avgeropoulos, MD
IRB No: 12.052.10
Secondary Protocol No: previous BTTC09-01
Applicable Disease Sites: Brain